TrialJournal of immunotherapy (Hagerstown, Md. : 1997)

Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma.

Bruce G Redman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.